Menu Close

Artikel-artikel mengenai COVID-19 vaccine boosters

Menampilkan semua artikel

The FDA advisory committee discussed vaccine safety, effectiveness of the current shots, potential seasonality of COVID-19 and more. wildpixel/iStock via Getty Images Plus

FDA advisory committee votes unanimously in favor of a one-shot COVID-19 vaccine approach – 5 questions answered

Many questions remain about next steps for US vaccine policy. But the FDA advisory panel’s hearty endorsement of a single-composition COVID-19 vaccine represents a pivotal step.
As of August 2022, COVID-19 vaccination rates in Black and Hispanic people exceeded those of white Americans nationally, but only for the initial shots. FatCamera/E+ via Getty Images

Low vaccine booster rates are now a key factor in COVID-19 deaths – and racial disparities in booster rates persist

Early on, public health messaging focused on the need for vaccines to combat COVID-19. But far less attention has been given to the role of boosters in preventing deaths and reducing inequities.
Shutterstock/Volurol

A new Omicron wave is upon New Zealand, with older people now most at risk – here’s what to expect

The last Omicron wave affected younger people. But the new BA.5 variant is seeing case numbers in older age groups higher than ever before – just as hospitals are under the most pressure.
Viral surveillance and prediction may be key parts of figuring out what goes into a vaccine. Pexels Cover/500px via Getty Images

Future COVID-19 booster shots will likely need fresh formulations as new coronavirus variants of concern continue to emerge

A new generation of vaccines and boosters against SARS-CoV-2 may take a page from the anti-influenza playbook, with shots periodically tailored to target the most commonly circulating virus strains.

Kontributor teratas

Lebih banyak